PT Maja Agung Latexindo TbkISX:SURI +1.64%28 EBITDA Margin % is 12.98% as of Mar. 2026, which is 315% above its 10-year median of 3.13. GuruFocus rates ISX:SURI with a GF Score™ of 28/100. The stock has 2 warning signs investors should review. Among 816 Medical Devices & Instruments companies, PT Maja Agung Latexindo Tbk ranks worse than 61.15% on this metric.
PT Maja Agung Latexindo Tbk (ISX:SURI) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
PT Maja Agung Latexindo Tbk EBITDA Margin % Related Terms
PT Maja Agung Latexindo Tbk EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:SURI vs ISRG, BDX, MDLN: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, PT Maja Agung Latexindo Tbk's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Maja Agung Latexindo Tbk EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PT Maja Agung Latexindo Tbk's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where PT Maja Agung Latexindo Tbk's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Maja Agung Latexindo Tbk (ISX:SURI) has a EBITDA Margin % of 12.98% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PT Maja Agung Latexindo Tbk and its competitors. This is 315% above median its historical median of 3.13. According to the industry distribution chart, PT Maja Agung Latexindo Tbk ranks #499 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 61.2%.
Is PT Maja Agung Latexindo Tbk's EBITDA Margin % too high?
PT Maja Agung Latexindo Tbk's current EBITDA Margin % of 12.98% is 315% above median its 10-year median of 3.13. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. PT Maja Agung Latexindo Tbk's value of 12.98% is 73.6% above this industry median. Based on the distribution chart, PT Maja Agung Latexindo Tbk ranks #499 out of 816 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, PT Maja Agung Latexindo Tbk has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does PT Maja Agung Latexindo Tbk's EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, PT Maja Agung Latexindo Tbk ranks #499 out of 816 companies for EBITDA Margin %. This places PT Maja Agung Latexindo Tbk in the lower half of its industry. The industry median EBITDA Margin % is 7.48. PT Maja Agung Latexindo Tbk's value of 12.98% is 73.6% above this benchmark. While the company's 10-year median is 3.13 vs. the industry median of 7.48, PT Maja Agung Latexindo Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Maja Agung Latexindo Tbk's current EBITDA Margin % of 12.98% is 73.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PT Maja Agung Latexindo Tbk and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Maja Agung Latexindo Tbk's current EBITDA Margin % is 12.98%, which is 315% above median its own 10-year median of 3.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Maja Agung Latexindo Tbk stock overvalued right now?
PT Maja Agung Latexindo Tbk (ISX:SURI) has a current EBITDA Margin % of 12.98%. The current EBITDA Margin % is 12.98%, which is 315% above median its 10-year median of 3.13 and 73.6% above the Medical Devices & Instruments industry median of 7.48. PT Maja Agung Latexindo Tbk's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For PT Maja Agung Latexindo Tbk (ISX:SURI), the current EBITDA Margin % is 12.98% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT Maja Agung Latexindo Tbk specializes in the production of latex gloves, made from natural rubber, and is a primary choice in the medical and industrial sectors. The company's business includes business of making rubber goods for health support needs, such as contraceptive gloves (birth control)/ condoms, pacifiers and compresses, medical rubber gloves, and urinary catheters (folley catheter). Its segments include Gloves and Concentrated latex.
28GF Score
Get the complete analysis for ISX:SURI
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SURI has been successfully added to your 
